Schizophrenia - Pediatric

Available for qualified participants

Schizophrenia - Pediatric

Available for qualified participants


CenExel CBH is seeking volunteers (ages 13-17) to participate in a child/teen clinical study on schizophrenia and/or psychosis. Schizophrenia is a disorder characterized by distorted perceptions of reality, including hallucinations, delusions and “disorganized” thinking and speech. These thoughts and feelings can be genetic, therefore if adult family members have a history of Schizophrenia and/or psychosis you should look out for the below symptoms on young adults and teenagers:

• hallucinations (hearing voices, or seeing or feeling things that are not there)
• delusions (beliefs that are not supported by reality)
• trouble thinking, such as feeling confused or “hazy”
• difficulty communicating clearly (other people are confused by what your child is saying).

Benefits for Children:

Your child will have access to new medicines that aren’t available to the public yet which researchers believe will work better or are safer than the standard.

Closer Monitoring/Additional Testing
Clinical trials also offer closer monitoring or additional testing for your child compared to regular care.

Helping Future Generations
By testing the safety and effectiveness of new medicines, your child is helping future generations find what works and what doesn’t. Participating in a clinical trial will help researchers and the public learn more about how to treat your child’s condition while becoming part of a community that understands what you’re going through.

The Process:

All study medication, assessments, and procedures related to the study will be provided at no cost to you.

Before you and your child decide whether to take part, we will provide you with all the information you need, and you both will have a chance to ask questions. You and your child will be given plenty of time to decide about taking part in the study. This study will help us learn more about the investigational medication.

For more information, please call a member of the study team. By contacting us, your child is under no obligation to take part in the study.

We have helped tens of thousands of patients in similar studies.
Space in this study is limited. To be considered, please fill out the form or call 301-251-4702.


Studies are currently available for qualified participants.


No health insurance required


Compensation for time and travel up to $5,150


Primary diagnosis of schizophrenia


Male / Female


13-17 years old


9318 Gaither Road, Ste 220
Gaithersburg, MD 20877

State of the Art Facilities

CBH is Maryland’s premier clinical research organization. For a decade, we’ve helped improve the quality of life for everyone by researching new medications and treatments. Our state-of-the-art facilities are held to the highest standards of cleanliness and quality.

Board Certified Physicians

Your safety is our greatest concern. Every procedure at CBH is overseen by expert medical staff and performed by some of the most well-respected board-certified physicians in the industry, each with many years of experience in their respective specialties.

FDA Approved Procedures

Rest assured, you are not signing up for treatment with “experimental” methods. CBH only uses FDA approved methods as if you were at any other hospital or clinic. Our research is focused on the medication associated with those methods.

Frequently asked questions

What is a CenExel Center of Excellence?

CenExel Centers of Excellence provide unparalleled medical and scientific support in the design and execution of clinical trials. Their attention to detail assures quality, reliable results and has helped CenExel to consistently achieve and exceed patient recruitment goals. They have conducted thousands of studies, the variety and complexity of which have resulted in a great depth of experience and insight for the principal investigators and research staff in each facility. CenExel Centers of Excellence deliver the engagement, expertise, and results to ensure that clients achieve their clinical research goals.

How do clinical trials work?

The study procedures and process will vary depending on the type of clinical trial you participate in. Before you begin a study, the process and all procedures for that study will be explained to you. Throughout the study, the Study Coordinator and the Principal Investigator will assist you and can answer any questions you have. They will check your health at the beginning of the trial, give you specific instructions for participating in the trial, monitor you carefully during the trial, and stay in touch with you after the study.

Some clinical trials involve more tests and doctor visits than you would normally have for your illness or condition. Your participation will be most successful if you carefully follow all instructions you are given and stay in contact with the research staff.

How safe are clinical studies?

There are many safeguards in place that all companies must follow when conducting clinical trials.

The Food and Drug Administration (FDA) is the regulatory agency that oversees all clinical research conducted in the United States. It is their responsible to protect the rights and as much as possible, the welfare of subjects participating in clinical trials. They ensure that data collected from clinical trials is of the highest quality and they are the agency that determines whether a new treatment should be sold in the US. Several organizations and individuals are governed by FDA regulations including clinical investigators, sponsors (the companies developing the treatments), Contract Research Organizations (companies that help conduct the studies), and Institutional Review Boards (groups that are responsible for ensuring the safety and welfare of study participants).

Good Clinical Practice (GCP) guidelines are another safeguard implemented to protect the safety of subjects. These guidelines encompass federal regulations and industry-accepted standards that govern clinical trials on humans. These regulations and standards apply to the conduct of the studies, record keeping, informed consent of subjects, collection of scientific data, and submission of information needed for the FDA to determine whether a new treatment should or should not be sold in the US. All companies must follow these guidelines when conducting clinical research.

An Institutional Review Board (IRB) is a committee that is formally tasked by an institution to review, approve, and monitor research involving human subjects. IRBs ensure that the risks to subjects are minimized; that subjects are adequately informed about the trial and the implications it will have on their treatment; that study protocols are modified, when necessary, to ensure safety; that risks are reasonable in relation to the anticipated benefits and the importance of the knowledge to be gained; that subject selection is equitable and that no classes of patients are discriminated against; that informed consent is obtained; that there is a provision for safety monitoring in the research plan; and that here are adequate provisions for the privacy and confidentiality for subjects and the data collected.